USPTO serial 79355607
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological preparations used in industry and science | ACTIVE | — |
| 005 | Pharmaceutical and veterinary pharmaceutical preparations and substances for treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; diagnostic preparations for medical purposes in the nature of treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; biopharmaceutical, biological and chemical preparations and substances for medical use in the nature of treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; pharmaceutical and veterinary pharmaceutical preparations and substances for the treatment of cancer, regulation of the immune system, treatment of diseases of the immune system and cell therapy | ACTIVE | — |
| 010 | Surgical and veterinary apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical diagnostic apparatus for testing blood cells, cancer cells and immune cells as therapeutic agents and modifications thereof; medical apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical apparatus and instruments for preparing and processing blood and other cell preparations for medical purposes in the nature of cancer treatment, regulation of the immune system and treatment of diseases of the immune system and cell therapy; medical apparatus and instruments for cell therapy; parts for the aforesaid goods, included in this class and only for purposes before mentioned | ACTIVE | — |
| 042 | Surgical and veterinary apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical diagnostic apparatus for testing blood cells, cancer cells and immune cells as therapeutic agents and modifications thereof; medical apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical apparatus and instruments for preparing and processing blood and other cell preparations for medical purposes in the nature of cancer treatment, regulation of the immune system and treatment of diseases of the immune system and cell therapy; medical apparatus and instruments for cell therapy; parts for the aforesaid goods, included in this class and only for purposes before mentioned. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 18, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 30, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 30, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 18, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 18, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 18, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 19, 2024 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| May 7, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 22, 2024 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Apr 22, 2024 | APET | ASSIGNED TO PETITION STAFF | — |
| Apr 17, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 17, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 13, 2024 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Feb 5, 2024 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 8, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 20, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 20, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 20, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 29, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 29, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 28, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 28, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 4, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 26, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 5, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 5, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 7, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 6, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 31, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 22, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 18, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 17, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |